Pharma Fights Healthcare Cost-Containment Policies - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharma Fights Healthcare Cost-Containment Policies
The ongoing economic crisis in Europe has accelerated healthcare cost-containment measures targeting the price of pharmaceuticals, but the pharma industry is not giving in without a fight.


The Guardian website, “The Euro Crisis is Over, Declares José Manuel Barroso,”, accessed 15 Jan. 2013.

Reuters website, “Europe Economic Recovery Seen Mid-2013 — ECB,” , accessed 15 Jan. 2013.

The Telegraph website, “Europe’s Bad Debts ‘Will Bite in 2013’,”, accessed 15 Jan. 2013.

EFPIA website, “Letter from EFPIA President, Sir Andrew Witty, to European Heads of States and Governments,”, accessed 15 Jan. 2013.

Swiss Info, “Recession-Hit Nations Owe Pharma Firms Billions,”, accessed 15 Jan. 2013.

PharmaTimes website, “Drugmakers Tell Greece: “We’ll Cap your Medicines Bill,”, accessed 15 Jan. 2013.

Business Week website, “Spain Drugmakers Plan $7 Billion Unpaid-Bill Securitization,”, accessed 15 Jan. 2013.

Chicago Tribune, “Spain Coughs Up Billions to Keep Regions in Medicine,”, accessed 15 Jan. 2013.


blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here